These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15034501)

  • 1. Vaccines and immunotherapies for the prevention of infectious diseases having cutaneous manifestations.
    Wu JJ; Huang DB; Pang KR; Tyring SK
    J Am Acad Dermatol; 2004 Apr; 50(4):495-528; quiz 529-32. PubMed ID: 15034501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines under study: non-HIV vaccines.
    Conner K; Wuu A; Maldonado V; Bartlett BL; Tyring SK
    Dermatol Ther; 2009; 22(2):168-85. PubMed ID: 19335728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New viral vaccines.
    Arvin AM; Greenberg HB
    Virology; 2006 Jan; 344(1):240-9. PubMed ID: 16364754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paediatric infections: prevention of transmission and disease--implications for adults.
    McIntosh ED
    Vaccine; 2005 Mar; 23(17-18):2087-9. PubMed ID: 15755576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of vaccine-preventable diseases.
    Solomon IH; Milner DA
    Histopathology; 2017 Jan; 70(1):109-122. PubMed ID: 27960239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Herpes simplex virus vaccine studies: from past to present].
    Us D
    Mikrobiyol Bul; 2006 Oct; 40(4):413-33. PubMed ID: 17205702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical content of preconception care: immunizations as part of preconception care.
    Coonrod DV; Jack BW; Boggess KA; Long R; Conry JA; Cox SN; Cefalo R; Hunter KD; Pizzica A; Dunlop AL
    Am J Obstet Gynecol; 2008 Dec; 199(6 Suppl 2):S290-5. PubMed ID: 19081423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
    Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
    Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccines for viral diseases with dermatologic manifestations.
    Brentjens MH; Yeung-Yue KA; Lee PC; Tyring SK
    Dermatol Clin; 2003 Apr; 21(2):349-69. PubMed ID: 12757257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Existing antiviral vaccines.
    Ravanfar P; Satyaprakash A; Creed R; Mendoza N
    Dermatol Ther; 2009; 22(2):110-28. PubMed ID: 19335723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How do physicians immunize their own children? Differences among pediatricians and nonpediatricians.
    Posfay-Barbe KM; Heininger U; Aebi C; Desgrandchamps D; Vaudaux B; Siegrist CA
    Pediatrics; 2005 Nov; 116(5):e623-33. PubMed ID: 16263976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America.
    Pickering LK; Baker CJ; Freed GL; Gall SA; Grogg SE; Poland GA; Rodewald LE; Schaffner W; Stinchfield P; Tan L; Zimmerman RK; Orenstein WA;
    Clin Infect Dis; 2009 Sep; 49(6):817-40. PubMed ID: 19659433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on universal childhood immunizations.
    Hamlin J; Senthilnathan S; Bernstein HH
    Curr Opin Pediatr; 2008 Aug; 20(4):483-9. PubMed ID: 18622208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of infectious diseases in older adults through immunization: the challenge of the senescent immune response.
    McElhaney JE
    Expert Rev Vaccines; 2009 May; 8(5):593-606. PubMed ID: 19397416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enteric vaccines.
    Edelman R; Levine MM
    Md Med J; 1991 Mar; 40(3):199-203. PubMed ID: 2008164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
    Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
    Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant vector derived from live attenuated measles virus: potential for flavivirus vaccines.
    Brandler S; Tangy F
    Comp Immunol Microbiol Infect Dis; 2008 Mar; 31(2-3):271-91. PubMed ID: 17869338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.